The first phase 2 clinical trial of a rectal microbicide (RM) candidate-a tenofovir-based, reduced-glycerin variant of the vaginal gel evaluated in CAPRISA-004 In addition to myriad social, cultural, and political factors that make MSM and TGW more vulnerable to HIV infection, 7 unprotected receptive anal intercourse itself is 10% to 20% riskier than unprotected vaginal intercourse. 8, 9 As Beyrer et al. note, if the transmission probability of unprotected receptive anal intercourse were similar to that of unprotected vaginal intercourse, the 5-year cumulative HIV incidence in MSM would drop by 80% to 90%. 5 Even partially efficacious RMs could play an important role in preventing new HIV infections, 10 but their effectiveness will rely on users finding such products acceptable and using them correctly and consistently.
The first phase 2 clinical trial of a rectal microbicide (RM) candidate-a tenofovir-based, reduced-glycerin variant of the vaginal gel evaluated in CAPRISA-004 1 -is under way in men who have sex with men (MSM) and transgender women (TGW) at 5 international sites. 2 If this product is found to be safe and acceptable, efficacy trials could begin by 2015, 3 leading to a new prevention option for people at risk for HIV infection during unprotected receptive anal intercourse. Especially for MSM and TGW, an HIV prevention option specifically for this type of intercourse is urgently needed. Despite a worldwide decrease in new HIV infections, 4 the epidemic continues to expand in MSM across all income levels globally, 5 and a recent meta-analysis placed the odds ratio for TGW being infected with HIV relative to all adults of reproductive age at 48.8. 6 In addition to myriad social, cultural, and political factors that make MSM and TGW more vulnerable to HIV infection, 7 unprotected receptive anal intercourse itself is 10% to 20% riskier than unprotected vaginal intercourse. 8, 9 As Beyrer et al. note, if the transmission probability of unprotected receptive anal intercourse were similar to that of unprotected vaginal intercourse, the 5-year cumulative HIV incidence in MSM would drop by 80% to 90%. 5 Even partially efficacious RMs could play an important role in preventing new HIV infections, 10 but their effectiveness will rely on users finding such products acceptable and using them correctly and consistently. 11, 12 Thus a body of acceptability research has emerged to examine the factors that may affect RM use, such as different product formulations (e.g., gels and lubricants, 13---16 suppositories, 17 and douches 18---20 ), the maximum volume of rectally applied product that users find tolerable, 21 frequency of use, cost effectiveness, and side effects. 22 Overall, acceptability research has demonstrated interest in a safe and effective RM among MSM and TGW 22---25 ; however, knowledge gaps remain. Particularly important to understand is how potential users see themselves interacting with RMs, including social, cultural, and political factors, all of which may affect the adoption of an HIV prevention technology. 26 We examined views of RMs among potential users in 3 South American cities to understand the sociocultural issues that could affect their uptake.
METHODS
During September 2009 to September 2010, we collected qualitative data via focus groups and individual, in-depth interviews conducted with MSM and TGW in Lima and Iquitos, Peru, and Guayaquil, Ecuador. We selected these cities because of their concentrated HIV epidemics: estimated HIV prevalence for Peru was 12.42% among MSM, 20.80% among TGW, 27 and 0.40% in the general population. 28 In Ecuador, the rate was 15.10% among MSM and TGW (separate HIV prevalence data specific to TGW were not available for Ecuador) and 0.31% in the general population. 29 
Recruitment and Data Collection
Peer outreach workers purposively recruited participants at venues that MSM and TGW frequented, including parks, beauty salons, volleyball courts, community organizations, bars, saunas, and nightclubs. Previous research studies conducted among the target populations in Peru and Ecuador informed the choice of these recruitment locations. 30---32 The peer outreach workers were MSM or TGW and thus had ready networks of potential participants from which to recruit. We screened interested persons for inclusion criteria (age ‡ 18 years, sexual intercourse with men during the previous 12 months) and, if eligible, randomly assigned them to either a focus group or in-depth interview, but not both.
We sought a heterogeneous sample of MSM and TGW. Therefore, the MSM sample comprised men who identified as openly gay (e.g., open with friends and family), men who did not identify as gay, and men who were sex workers. We chose these 3 groups along with TGW to ensure inclusion of various types of RM users and were guided by our previous research studying the acceptability of preexposure prophylaxis 30 and male circumcision 33 in the same cities. Because participants could belong to more than 1 of the 4 recruitment groups (e.g., a gay man who also sold sex), they were asked to choose the group with which they most identified. We chose 2 data collection methods to balance the breadth of ideas and opinions afforded by focus groups with the more indepth and often personal information yielded by individual interviews. We used nearly identical semistructured interview guides for the focus groups and interviews (Table 1) . We began the focus groups and interviews by asking participants what they knew about RMs, prior to providing any explanation. Next, we told participants that RMs were "substances-for example, gels, creams, lubricants or liquids-that could be inserted rectally before having anal sex in order to reduce the possibility of becoming infected with HIV." We asked participants to discuss their views of RMs as well as their perceptions of the opinions of their peers. The focus groups and interviews lasted approximately 60 minutes. We collected sociodemographic information at the end of the sessions with a self-administered questionnaire.
Data Analysis
We digitally recorded the focus groups and interviews, transcribed them verbatim, and analyzed them with ATLAS.ti version 6.0 (ATLAS.ti Scientific Software Development GmbH, Berlin, Germany). We used framework analysis, 34 reading each transcript in its entirety, reading it a second time, and assigning representative codes to emergent themes as we detected them. Although we determined some codes a priori according to the predefined questions, we created other codes de novo as new themes emerged. We reread text passages multiple times and refined coding during the iterative analytic process.
We extracted text by culling all passages with the same code across the entire data set, formatting them into tables, and then translating them into English. One investigator read the extracted, translated text and independently verified the codes. We discussed discrepancies and resolved them by mutual agreement. We combined very similar and overlapping codes into single codes and grouped families of codes by thematic likeness. Finally, we chose specific quotations to illustrate the emergent themes.
RESULTS
Sociodemographic characteristics are listed in Table 2 . We conducted 1 focus group per Social and community concerns What are possible social concerns that may discourage you or your close friends' from using RMs?
Any issues with accessing condoms or lubricants currently-any previous experiences?
Where would you prefer to get an RM? recruitment group type (i.e., gay, nongay, sex worker, and TGW) per city. Each group had 7 to 10 participants, totaling 104 participants in 12 groups. We also conducted 3 in-depth interviews in each city with participants from each recruitment group type, totaling 36 in-depth interviews. Among all participants in the focus groups and interviews, 33 were gay, 37 were nongay, 35 were sex workers, and 35 were TGW (n = 140). We identified 5 major topic areas affecting RM uptake and use: (1) knowledge, (2) product issues, (3) impact on condom use, (4) target users, and (5) social aspects. Table 3 lists additional quotes regarding each topic area.
Knowledge
Few participants had heard of RMs prior to study participation. Some participants correctly guessed that RMs were something that could kill HIV, but others thought "rectal microbicide" referred to a disease related to HIV that was spread between men:
Some infection regarding HIV disease-oh!-even another type of risk that one has when having sex with another man!-TGW, focus group Another respondent went a step further in his explanation:
[It's] some virus that can cause death, something like that?-Gay participant, interview
Product Issues
Participants questioned the plausibility of an RM to prevent HIV, wondering how it could cover the entire anorectal canal and what would happen if sperm "jumped" over the microbicide. One participant thought that claims of an effective RM would be a "lie":
I don't think that the microbicide is going to reach the entire width of -what's it called? -the anal canal. So for me, well, that means that if they say that this is going to be beneficial for me, I would say that would be a lie because that microbicide is not going to reach the entire anus. So, people will see it as a joke.-TGW, focus group Another common expectation was the assurance that the RM would be completely effective:
[I]f we are going to use it, we have to be really 100% sure that it's going to work as such. We should be clear that we aren't going end up with, you know, with . . . HIV.-Nongay participant, focus group A related issue stemming from product effectiveness was an assumption that if an RM prevents HIV infection then it must be a "disinfectant" that could harm the body by "entering the bloodstream" and getting into "our organs." Participants wondered how an RM would "kill" HIV on contact but not harm one's body:
Maybe someone thinks that it's going to destroy everything, anything it comes in contact with, whether that be a liquid, whether that be semen, but at the same time it won't touch . . . it won't cause damage to our walls.-Sex worker, focus group A final product-related concern was the potential for side effects for persons with preexisting skin conditions or diseases. A specific concern regarded the use of RMs with a partner who had HIV and the risk to which that might expose him: Note. Because of missing data, variables do not sum to total sample sizes. . . . alive that moves. I mean, it's going to go through the entire body . . . and the gel only is going to stay in that one part. I don't trust it, I mean, personally I wouldn't trust it. I would use it with condoms."
TGW interviewee: "As I was saying, I doubt that it would protect in the case of men who do the penetration and all that due to the semen, which I think flows rapidly?" Interviewer: "Yes, it comes out forcefully."
TGW interviewee: "Exactly, most of all it could easily get past the microbicide. Up to what point will would this microbicide have protection? Because the rectum is a tube." Interviewer: "Yes."
TGW interviewee: "And I mean, is it going to reach the end [of the anus]? Or is it only going to reach up to a determined zone and then maybe sperm that determined zone could be jumped over by the sperm?" Interviewer: "Yes, that's why it's being looked into."
TGW interviewee: "It's complicated, isn't it?" Gay focus group participant 1: "I think that it won't protect that much, I mean, if it comes in a gel form or something like that, it would only go on the outside and, I don't know, no, I think that it should come in a different form, like a suppository, something like that, that is going to protect you even more. Interviewer: "Yeah, because hygiene is also an issue, it's not just HIV. Of course there's prevention, but it's also a hygiene issue." Nongay interviewee: "Yeah. Awhile ago I met someone also coincidentally, and he told me, 'Oh no, I always use a condom so it is clean and so forth, but aside from that you are protecting yourself,' he said, 'You also avoid infection.' And it's true, an infection is ugly, right? You feel . . . it's horrible, you get bumps and whatever."
People are used to condoms TGW focus group participant: "They are never going to disappear from the market, because they came out first. People are used to, completely used to, using condoms."
Target users Activo
Sex worker interviewee: "The activos of course, the activos are the ones who penetrate. So, for them it would be easier, it would no longer be necessary to use a condom, but rather you'd just apply the cream and nothing more."
Pasivo TGW focus group participant: "I think that we, the pasivas, should prevent things more than the men." Gay interviewee: "Well, when I go to buy products, I prefer to do it in a place that is not so close to my home or work." Interviewer: "You go somewhere where they don't know you."
Moderno
Gay interviewee: "Somewhere where they don't know me." Interviewer: "I have heard something similar. It's like a strategy that some people use to maintain their confidentiality."
Gay interviewee: "I have friends who are very sexually active, but they don't like to go, they have never gone to a pharmacy for condoms. I mean, they prefer that some other person waits on them."
Stigma and Discrimination Gay focus group participant: "We are used to sex, and anal sex is socially seen as sex against nature. It's something that's prohibited by religions, right? So, socially the RM name is already going to be a . . . label . . . completely for homosexuals, right? But it's not going to be used a lot in the hetero environment, right?"
Nongay interviewee: "If there are people that are against condoms, they will also be against microbicides. They could be the same people or they could be others, the church, etc."
Note. Activo = insertive partner; moderno = both insertive and receptive partner; pasivo = receptive partner; RM = rectal microbicide; TGW = transgender woman.
"bareback sex" and the viewpoint that HIV is a treatable "chronic infection."
[The condom] would be left behind, no one would use it . . . because people like it bareback and if there's a second option, they would stop using condoms.-Nongay participant, focus group
RMs were also viewed as a viable alternative to condoms, especially among sex workers, with whom condomless sex was sometimes incentivized:
The clients like it without condoms. For example, there are people that pay you for that.-Sex worker, interview RMs were seen as displacing condoms if they were at least as effective as condoms because of the perception that they would be "easier" and "less bothersome" to use and would provide greater sexual sensitivity if formulated as a lubricant:
[F]or example, if I were really sure that it was 100% protective, well, I think that without a condom is much better. It's true! I would stop using condoms and I would use this.-Nongay participant, focus group However, use of RMs as a backup in case of condom breakage was repeatedly mentioned as the preferred usage modality among these men:
But it should come out with condoms, along with condoms, in that way it also comes with protection so that if it breaks then [the microbicide] protects you, right?-Gay participant, interview Participants also noted that condoms would not be abandoned because they were also used for hygiene and for protection from other sexually transmitted infections and because "they are what people are used to."
Target Users
Some participants felt that RMs should target the activo (insertive) partner because he is "the penetrator" and "more at risk of infection"; others felt that it was the pasivo (receptive) partner who would benefit more from the RM.
To me it seems the activo, since it's he who will catch a disease.-Sex worker, focus group [An RM is] more for the pasivas and even more for the sex workers.-TGW, focus group Several participants said that men like "to give and receive" (i.e., sometimes be activo and sometimes be pasivo, or moderno [both insertive and receptive]), and the RM should be used by both:
Both, because there are even activos that do it as pasivos as well, right? There are pasivos that do it as activos, too.-Nongay participant, focus group
Social Issues
Primary among social issues was the embarrassment one might feel when buying a product specifically for anal intercourse, and many participants recounted that even buying condoms was uncomfortable and often done in pharmacies far from their home or workplace to preserve anonymity. The risk of being discovered and labeled as someone who has sex with other men when buying RMs was worrisome:
It would cause a bit of . . . uneasiness [to buy it], right? Because it's not the same as buying a condom because the people selling them don't know with whom you are going to have sex. However, if it were [an RM], the clerk is going to think that you're going to have anal sex, he is not going to think that you're going to do it with a woman, undoubtedly he is going to say that it is with a fag, with a gay.-Sex worker, interview Another issue raised was the difficulty a man who was closeted would have in buying RMs: 
DISCUSSION
In a South American population of potential RM users, we used qualitative methods to explore the sociocultural issues that may affect the uptake of RMs. We noted some differences between the groups: for example, men in the nongay group were particularly concerned about RM access and the risk of being labeled a homosexual or someone who has sexual intercourse with homosexuals. On the whole, however, participants were homogeneous in their views across the topic areas, regardless of recruitment group.
Although some participants had heard of RMs, most had not, and guesses as to the meaning of "rectal microbicide" frequently generated ideas of infection, disease, and death. We also heard worries about the plausibility of RMs' ability to prevent HIV infection, particularly regarding product coverage of the entire anal canal, an issue that has been studied by RM developers. 35 In addition, participants worried about potential side effects for people living with HIV who might come in contact with an RM. Although participants did not extensively articulate this worry, some RM developers have noted that the effect of antiretroviral-based microbicides on untreated persons with HIV could be problematic because it would amount to monotherapy, potentially leading to HIV resistance. 36 This would be deleterious for people with HIV because it might limit their treatment options, and it has broader public health implications because drug-resistant HIV strains might be passed to others. 12 These concerns are indicative of the type of information and education that potential RM users will need (e.g., what RMs are, how they work, their limitations, and the need for regular HIV testing) before deciding to use such products. Concerns have also been expressed that biomedical prevention interventions could cause risk compensation and the abandonment of condoms for anal intercourse in favor of new, partially efficacious HIV prevention technologies, thereby leading to more HIV infections. 37 Our data only partially supported this view. Although study participants felt that RMs would be used by those who prefer condomless intercourse, a more predominant cluster of themes positioned RMs for people who have already abandoned condoms or as a supplement rather than a replacement for condoms. Among participants who liked the idea of RMs for their simplicity and potential to restore sexual sensitivity lost with condom use, condom abandonment was only foreseen if RMs were at least as protective as condoms. These results have mixed implications. We did not find evidence of an envisioned mass migration to RMs, although it is possible that condom replacement could occur among those who may wish to use condoms but cannot (e.g., sex workers who are paid more for not using condoms). However, the expectation that RMs will be highly effective is concerning, because the efficacy of first-generation RMs is predicted to be between 40% and 80%. 22 These issues beg the question of how RMs, which will likely be less efficacious than male condoms (considered to be up to 95% effective in preventing HIV infection when used correctly and consistently 38 ), will be targeted only to those who will most benefit from them. In health care settings, a suggested approach is to include RMs as part of a comprehensive HIV prevention service, targeting them to persons who do not or cannot use condoms for receptive anal intercourse. Such a strategy would include risk reduction and product adherence counseling, condoms, and testing and treatment of other sexually transmitted infections, a strategy that follows the US Centers for Disease Control and Prevention's guidelines for the use of preexposure prophylaxis. 39 We did not screen participants according to sexual position (activo or pasivo) because it is important to understand the insertive partner's views on purchasing and applying the product with the receptive partner. We found no consensus on which type of partner-activo or pasivo-would be more likely to use RMs, despite our explanation that they were intended for the receptive partner. Participants noted that not everyone adheres to strict role differentiation-many enjoy both the activo and pasivo roles, and 64% of our study sample reported role versatility (Table 2) . Also, sexual roles, identities, and behaviors among Latin American MSM may be conceptualized and expressed differently than in other cultures. For example, 8% of our participants selfidentified as heterosexual even though all reported having sex with men. In another recent study in Peru, among 170 MSM who self-identified as activo, 6.4% reported unprotected receptive anal intercourse in the previous 6 months and 77% self-identified as heterosexual. 40 Thus the activos in our study may have drawn on their experience as the receptive partner in forming their opinions about using RMs. As RM research expands further into international settings with differing sexual typologies, it will be necessary to extend inquiry beyond those who identify explicitly as the gay receptive partner, because failure to do so will miss people who have unprotected receptive intercourse and are at risk for HIV. Social and community concerns regarding RMs included uneasiness when purchasing a product that, unlike condoms, is explicitly for anal intercourse and thus considered to "prove your homosexuality." These issues are illustrative of an overarching theme of homoprejudice (and resultant stigma and discrimination), 41 which is a powerful barrier to accessing HIV prevention and care services. 42---45 RMs, participants felt, would be seen not as "just another type of lubricant" but as an indictment of one's sexual identity, a stigmatizing mark branding the person as a sexual deviant, a "fag," or someone with AIDS. Thus, the fear of being labeled in this way could be a strong deterrent to purchasing RMs. Changing cultural attitudes toward anal intercourse and homosexuality is a long-term process, unlikely to be achieved quickly; therefore, practical solutions to address RM access are needed. Distribution methods should be accessible and respectful of user privacy. A range of options should be considered, such as recruiting nongovernmental organizations and peer outreach teams to provide delivery (e.g., to sex workers in their congregation areas, much as condoms are distributed now) and working with select pharmacies to provide sensitivity training so that consumers are more comfortable purchasing the product. Although a strength of qualitative data is the ability to particularize a topic, the results are not generalizable to all South American MSM and TGW. Our sample was relatively young (< 40 years), educated, and employed, similar to samples in other HIV studies on MSM and TGW in Peru and Ecuador.
27,46,47 Therefore, our findings may not apply to older, less educated, unemployed MSM and TGW. Ours was the first study to explore aspects potentially affecting RM use in samples of likely users in South America. As with all HIV prevention interventions, RMs will not be used in a sociocultural vacuum but instead woven into the everyday lives of those they are intended to help. 48 We identified multiple issues that may influence RM use, including concerns regarding what RMs are, how they would work, who would use them, and the challenges in accessing them. Now that RMs have moved into larger clinical trials, the time is ripe to educate both potential users and those who will mediate their access (e.g., policymakers, physicians, health care workers, pharmacists). By addressing these issues now, we can speed access to this desperately needed HIV prevention intervention for MSM and TGW once it is available. j
